Medicine Price Manipulation in India 2026

Overview

What This Investigation Is About

India's online pharmacy market crossed ₹22,000 crore in FY2026, growing at 29% year-on-year. Millions of Indians now purchase prescription and over-the-counter medicines from platforms like PharmEasy, 1mg, Netmeds, Apollo Pharmacy, Tata 1mg, and MedPlusMart — trusting that prices are fair, availability is accurate, and discounts are genuine.

This report exposes a systemic problem: pharmaceutical price manipulation is widespread across India's leading online pharmacy platforms. Actowiz Solutions scraped and analysed pricing data, discount patterns, availability signals, and MRP declarations across 6 major platforms for 10,000+ medicine SKUs over 6 months. What we found — inflated MRPs, phantom discounts, selective unavailability, and fake review patterns — has direct implications for patients, regulators, hospitals, pharma brands, and healthcare investors.

Every data point in this report was captured by Actowiz's proprietary pharmaceutical price intelligence scraping infrastructure, cross-referenced with NPPA (National Pharmaceutical Pricing Authority) ceiling prices, Jan Aushadhi MRP data, and offline retail prices from 120+ cities. This is the most comprehensive independent data investigation of online pharmacy pricing in India published in 2026.

Who should read this: Pharma brand managers, hospital procurement teams, healthcare regulators, retail pharmacy chains, healthcare investors, and patient advocacy organisations.

Key Takeaways

6 Findings That Expose India's Online Pharmacy Pricing Reality

1. MRP inflation is systematic — Based on NPPA Ceiling Price Comparison. Actowiz found that 44% of analysed SKUs across all 6 platforms showed MRP declarations more than 20% above the NPPA ceiling price or Jan Aushadhi reference price. This is not rounding — it is a deliberate pricing architecture designed to manufacture the appearance of discounts.
2. The '20% off' discount — Analysing Discount Authenticity Patterns across platforms. Every platform advertises flat 20%+ discounts on medicines. Our data shows that in 61% of cases, the pre-discount price (the 'MRP' shown) is itself inflated by 25–40% above the true market reference price. The 'discount' brings consumers back to — or above — fair market price.
3. Availability manipulation drives platform stickiness. Actowiz availability scraping found that 28% of medicines showing 'Out of Stock' on one platform were simultaneously available at a higher price on another. Selective OOS signals are being used to push consumers toward higher-margin products and platforms.
4. PharmEasy and 1mg charge the most — Netmeds discounts most genuinely. Across 500 high-volume medicine SKUs, PharmEasy's effective prices (post-discount) were on average 12.4% higher than Netmeds and 8.1% higher than Apollo Pharmacy. Netmeds consistently offered the lowest net prices for generics. 1mg showed the widest price variance — best for some SKUs, worst for others.
5. Generic substitution is being suppressed by pricing signals. NPPA-approved generic equivalents are available at 60–90% lower cost for most branded medicines. Yet branded versions account for 78% of sales on all 6 platforms. Platform search algorithms rank branded products first, and generic alternatives are buried or unlisted — despite the Drugs and Cosmetics Act obligation to offer them.
6. Review manipulation is highest in the vitamins and supplements category. Actowiz fake review detection flagged 51% of top-rated vitamin and supplement products across all platforms as showing coordinated, incentivised, or AI-generated review patterns — far above the 38% average for general e-commerce. This category operates with minimal CDSCO oversight.

Real Results from Real Clients

Hear It Directly from Our Clients

Watch how businesses like yours are using Actowiz data to drive growth.

▶

1 min

★★★★★

"Actowiz Solutions offered exceptional support with transparency and guidance throughout. Anna and Saga made the process easy for a non-technical user like me. Great service, fair pricing!"

Thomas Galido

Co-Founder / Head of Product at Upright Data Inc.

▶

2 min

★★★★★

"Actowiz delivered impeccable results for our company. Their team ensured data accuracy and on-time delivery. The competitive intelligence completely transformed our pricing strategy."

Iulen Ibanez

CEO / Datacy.es

▶

1:30

★★★★★

"What impressed me most was the speed — we went from requirement to production data in under 48 hours. The API integration was seamless and the support team is always responsive."

Febbin Chacko

-Fin, Small Business Owner

4.8/5 Average Rating

50+ Video Testimonials

92% Client Retention

50+ Countries Served

Why Global Leaders Trust Actowiz

Backed by automation, data volume, and enterprise-grade scale — we help businesses from startups to Fortune 500s extract competitive insights across the USA, UK, UAE, and beyond.